Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial (vol 356, pg 1384, 2000)

Authors
Bergh, J
Citation
J. Bergh, Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial (vol 356, pg 1384, 2000), LANCET, 356(9248), 2000, pp. 2196-2196
Citations number
1
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
356
Issue
9248
Year of publication
2000
Pages
2196 - 2196
Database
ISI
SICI code
0140-6736(200012)356:9248<2196:TFEACC>2.0.ZU;2-G